World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
80
Citations
16684
World Ranking
1655
National Ranking
817

Medicine

D-Index
80
Citations
16792
World Ranking
17320
National Ranking
8678

Overview

Philip O. Livingston is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research spans multiple fields, including Medicine, Biochemistry, Genetics and Molecular Biology, as well as Immunology and Microbiology. Within these broader disciplines, they have contributed to subfields such as Neurology, Biotechnology, and Immunology.

Their work is focused on several interconnected topics, primarily centered around Neuroblastoma Research and Treatments, Cancer Research and Treatments, and Immunotherapy and Immune Responses. These areas reflect an emphasis on understanding and developing therapeutic approaches to cancer, particularly in immunological contexts.

Livingston has coauthored publications with a number of researchers, including Evan Rosenbaum, Rashmi Chugh, Christopher W. Ryan, Mark Agulnik, and Mohammed Milhem. Collaborative efforts with these colleagues have contributed to the scientific output associated with their profile.

Their recent publication is titled A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery, published in 2022 in the European Journal of Cancer. This paper has accumulated citations, indicating its engagement within the research community.

The European Journal of Cancer is noted as a frequent publication venue for Livingston's work, representing a platform for dissemination of findings related to cancer research.

Best Publications

  • Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides

    Shengle Zhang;Carlos Cordon-Cardo;Helen S. Zhang;Victor E. Reuter

  • Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens

    Shengle Zhang;Helen S. Zhang;Carlos Cordon-Cardo;Victor E. Reuter

  • Selective CD4+ Lymphopenia in Melanoma Patients Treated With Temozolomide: A Toxicity With Therapeutic Implications

    Y.B. Su;Sejean Sohn;Susan E. Krown;Philip O. Livingston

  • Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

    Philip O. Livingston;Edward J. Natoli;Michele Jones Calves;Elisabeth Stockert

  • Carbohydrate vaccines in cancer: Immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man

    S. F. Slovin;G. Ragupathi;S. Adluri;G. Ungers

  • Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma

    Philip O. Livingston;Sucharita Adluri;Friedhelm Helling;Tzy-Jyun Yao

  • GM2-KLH Conjugate Vaccine: Increased Immunogenicity in Melanoma Patients after Administration with Immunological Adjuvant QS-21

    Helling F;Zhang S;Shang A;Adluri S

  • GD3 Vaccines for Melanoma: Superior Immunogenicity of Keyhole Limpet Hemocyanin Conjugate Vaccines

    Friedhelm Helling;Ann Shang;Michele Calves;Shengle Zhang

  • Synthetic and Immunological Studies on Clustered Modes of Mucin-Related Tn and TF O-Linked Antigens: The Preparation of a Glycopeptide-Based Vaccine for Clinical Trials against Prostate Cancer†

    Scott D. Kuduk;Jacob B. Schwarz;Xiao-Tao Chen;Peter W. Glunz

  • Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.

    Teresa Gilewski;Sucharita Adluri;Govindaswami Ragupathi;Shengle Zhang

  • Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes

    Hans H. Wandall;Ola Blixt;Mads A. Tarp;Johannes W. Pedersen

  • Expression of Potential Target Antigens for Immunotherapy on Primary and Metastatic Prostate Cancers

    Shengle Zhang;H. S. Zhang;V. E. Reuter;S. F. Slovin

  • Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: A phase I trial

    Teresa Gilewski;Govindaswami Ragupathi;Sonal Bhuta;Lawrence J. Williams

  • Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.

    Susan F. Slovin;Govindaswami Ragupathi;Cristina Musselli;Krystyna Olkiewicz

  • Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer.

    Govind Ragupathi;Jeffrey R Gardner;Philip O Livingston;David Y Gin

  • Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate Vaccines

    Philip O. Livingston

  • Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.

    Wm. Bradley Hamilton;Friedhelm Helling;Kenneth O. Lloyd;Philip O. Livingston

  • Preparation and evaluation of unimolecular pentavalent and hexavalent antigenic constructs targeting prostate and breast cancer: a synthetic route to anticancer vaccine candidates.

    Govind Ragupathi;Fusataka Koide;Philip O. Livingston;Young Shin Cho

  • A Fully Synthetic Therapeutic Vaccine Candidate Targeting Carcinoma-Associated Tn Carbohydrate Antigen Induces Tumor-Specific Antibodies in Nonhuman Primates

    Richard Lo-Man;Sophie Vichier-Guerre;Ronald Perraut;Edith Dériaud

  • Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma.

    Wen Jen Hwu;Susan E. Krown;Jennifer H. Menell;Katherine S. Panageas

Frequent Co-Authors

Herbert F. Oettgen
Herbert F. Oettgen Memorial Sloan Kettering Cancer Center
Samuel J. Danishefsky
Samuel J. Danishefsky Columbia University
Alan N. Houghton
Alan N. Houghton Memorial Sloan Kettering Cancer Center
Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Kenneth O. Lloyd
Kenneth O. Lloyd Memorial Sloan Kettering Cancer Center
Paul B. Chapman
Paul B. Chapman Memorial Sloan Kettering Cancer Center
Katherine S. Panageas
Katherine S. Panageas Memorial Sloan Kettering Cancer Center
Jedd D. Wolchok
Jedd D. Wolchok Cornell University
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Gerd Ritter
Gerd Ritter Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, exploring related healthcare degrees can open diverse career opportunities. Many aspiring healthcare professionals begin with practical nursing programs. Finding programs that are accessible is crucial, and understanding which lpn programs are easiest to get into can help streamline your entry into the nursing field.

As you advance, nurse practitioner degrees offer specialized knowledge and broaden your career options. Those seeking efficient paths often look for clarity on what is the easiest np program, ensuring effective completion while gaining critical skills.

For those drawn to mental health, psychiatric nursing holds a vital role. Pursuing top-quality programs with excellent clinical experiences is essential. Checking out best psychiatric mental health nurse practitioner programs online provides valuable insights into reputable options with strong hands-on training.

Cost is a significant factor for many students, especially for specialized certifications. To manage expenses wisely, it’s beneficial to explore the cheapest pmhnp certificate programs available to find affordable pathways that don’t compromise quality.

Best Scientists Citing Philip O. Livingston

Trending Scientists